About this reference material
CJC-1295 is a modified analogue of the first twenty-nine residues of growth hormone releasing hormone, carrying amino acid substitutions intended to resist enzymatic degradation. It is cited in receptor pharmacology literature as a GHRH receptor reference ligand.
This compound is supplied in more than one form across the research supply market, with and without the drug affinity complex modification. The form and purity of the lot you receive are stated on its certificate of analysis and should be read from that document rather than from this listing.
Handling and storage
Supplied as a lyophilized powder in a sealed vial. Store sealed vials at -20°C, protected from light and moisture. Allow the vial to reach room temperature before opening. Reconstituted material should be held refrigerated, protected from light, and handled under the receiving laboratory’s own protocols.
Documentation
Each production lot is analyzed by an independent third-party laboratory before release. The purity and identity result for the lot you receive is stated on its certificate of analysis, which is published against the lot number printed on the vial label.
Research use only
This product is supplied strictly for in-vitro laboratory research use. It is not a medicine, is not approved by any medicines regulator, and is not for human or veterinary consumption, or for diagnostic, therapeutic, food, cosmetic or household use. Sale is restricted to persons aged 18 or over who are qualified researchers or who purchase on behalf of a research institution, laboratory or business. The purchaser is solely responsible for handling, storage, disposal and for compliance with all federal, state and local laws that apply to their own work.



